VCR vs XBI
Vanguard Consumer Discretionary ETF vs SPDR S&P Biotech ETF
- • VCR has the lower expense ratio at 0.09% vs 0.35% for XBI.
- • VCR pays a higher dividend yield (0.78%).
Side-by-side metrics
| Metric | VCR | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.09% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.78% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $6.49B | $10.92B |
YTD return | 3.02% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.17 | 1.01 |
P/E ratio | 24.05 | — |
Last price | $402.51 | $156.41 |
Inception | — | — |
Issuer | Vanguard | State Street |
VCR top holdings
| AMZN | Amazon.com Inc | 22.99% |
| TSLA | Tesla Inc | 15.91% |
| HD | The Home Depot Inc | 4.52% |
| MCD | McDonald's Corp | 2.64% |
| TJX | TJX Companies Inc | 2.37% |
| BKNG | Booking Holdings Inc | 2.07% |
| SBUX | Starbucks Corp | 1.74% |
| LOW | Lowe's Companies Inc | 1.68% |
| MAR | Marriott International Inc Class A | 1.32% |
| MELI | MercadoLibre Inc | 1.30% |
XBI top holdings
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
About VCR
VCR (Vanguard Consumer Discretionary ETF) is US consumer discretionary sector stocks. Managed by Vanguard, the fund carries $6.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 0.78%. Its largest holding is Amazon.com Inc (AMZN), which represents 23.0% of the portfolio. Real Estate is the fund's largest sector exposure at 0.1%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.